PL372453A1 - Wariant wirusa zakaźnego zapalenia torby Fabrycjusza - Google Patents

Wariant wirusa zakaźnego zapalenia torby Fabrycjusza

Info

Publication number
PL372453A1
PL372453A1 PL37245303A PL37245303A PL372453A1 PL 372453 A1 PL372453 A1 PL 372453A1 PL 37245303 A PL37245303 A PL 37245303A PL 37245303 A PL37245303 A PL 37245303A PL 372453 A1 PL372453 A1 PL 372453A1
Authority
PL
Poland
Prior art keywords
disease virus
bursal disease
infectious bursal
virus variant
variant
Prior art date
Application number
PL37245303A
Other languages
English (en)
Other versions
PL209994B1 (pl
Inventor
Loon Adriaan Antonius Wilhelmus Maria Van
Paul Guntram
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of PL372453A1 publication Critical patent/PL372453A1/pl
Publication of PL209994B1 publication Critical patent/PL209994B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL372453A 2002-03-01 2003-02-25 Wariant wirusa zakaźnego zapalenia torby Fabrycjusza (IBDV), szczepionki, sposób wytwarzania wariantu IBDV, sposób wytwarzania szczepionek, zastosowanie wariantów IBDV PL209994B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02075881 2002-03-01
EP02079827 2002-11-21
PCT/EP2003/001905 WO2003074552A1 (en) 2002-03-01 2003-02-25 An infectious bursal disease virus variant

Publications (2)

Publication Number Publication Date
PL372453A1 true PL372453A1 (pl) 2005-07-25
PL209994B1 PL209994B1 (pl) 2011-11-30

Family

ID=27790100

Family Applications (1)

Application Number Title Priority Date Filing Date
PL372453A PL209994B1 (pl) 2002-03-01 2003-02-25 Wariant wirusa zakaźnego zapalenia torby Fabrycjusza (IBDV), szczepionki, sposób wytwarzania wariantu IBDV, sposób wytwarzania szczepionek, zastosowanie wariantów IBDV

Country Status (4)

Country Link
EP (1) EP1483287A1 (pl)
AU (1) AU2003227026A1 (pl)
PL (1) PL209994B1 (pl)
WO (1) WO2003074552A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050214316A1 (en) * 2003-11-13 2005-09-29 Brown Thomas P Methods of characterizing infectious bursal disease virus
CA2557844C (en) * 2004-03-12 2016-06-21 Wyeth Infectious bursal disease virus antigenic isolates and vaccines
ES2310062B1 (es) 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
CN103232974B (zh) * 2013-03-18 2014-09-03 江苏省农业科学院 分泌高中和活性传染性法氏囊病毒单克隆抗体的杂交瘤细胞
CN109320594B (zh) * 2018-11-13 2021-09-28 四川大学 一种禽传染性支气管炎和新城疫的病毒样颗粒、制备方法及应用
CN112501129B (zh) * 2020-12-14 2022-12-02 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 抗ibdv vp2蛋白的单克隆抗体组合及其在鉴别检测ibdv中的用途
CN112500458B (zh) * 2020-12-15 2022-12-16 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 鸡传染性法氏囊病病毒新型变异株亚单位疫苗、其制备方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
EP1170302B1 (en) * 2000-07-07 2006-06-21 Intervet International BV Infectious bursal disease virus vaccines

Also Published As

Publication number Publication date
AU2003227026A1 (en) 2003-09-16
WO2003074552A1 (en) 2003-09-12
EP1483287A1 (en) 2004-12-08
PL209994B1 (pl) 2011-11-30

Similar Documents

Publication Publication Date Title
AU2002367748A8 (en) Infectious disease microarray
IL174403A0 (en) Macrocyclic peptides active against the hepatitis c virus
PL371007A1 (pl) Peptydy makrocykliczne aktywne przeciw wirusowi zapalenia wątroby typu C
EP1684787A4 (en) INHIBITORS OF HEPATITIS C VIRUS
EP1684745A4 (en) INHIBITORS OF HEPATITIS C VIRUS
DE60327184D1 (de) Abgasreinigungsfilter
DK1523329T3 (da) Viruspartikeladjuvant
ZA200501034B (en) Infectious disease surveillance system.
AU2003206862A8 (en) Hepatitis b vaccines
PL376967A1 (pl) Szczepionka przeciw HCV
EP1692279A4 (en) VIRUS PREPARATIONS CONTAINING A CONSERVATIVE
AU2003301850A8 (en) Hiv vaccine
IL147605A0 (en) Mosaic infectious bursal disease virus vaccines
AU2003294757A8 (en) Formulations useful against hepatitis c virus infections
PL374569A1 (pl) Szczepionki
PL372453A1 (pl) Wariant wirusa zakaźnego zapalenia torby Fabrycjusza
DE60334226D1 (de) Vakzine gegen infektiöse katzen-peritonitis
GB0328753D0 (en) Hepatitis B vaccines
AU2002310654A1 (en) Bursal disease virus-like particles
EP1605763A4 (en) ADMINISTRATION OF NEWCASTLE DISEASE VIRUS
AU2000252449A1 (en) Recombinant vaccines against infectious bursal disease virus
IL177903A (en) Vaccine for Infectious Stock Disease Virus and its Use
AU2003256404A8 (en) Hepatitis c virus assays
HUP0102823A3 (en) A broad spectrum infectious bursal disease virus vaccine
AU2003225479A1 (en) Reporter-selectable hepatitis c virus replicon